Aspira Women's Health, Inc. (AWH) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Spero Therapeutics, Inc.

Shattuck Labs, Inc.

Aspira Women's Health, Inc.

Enzo Biochem, Inc.

Avrobio, Inc.

Nkarta, Inc.

Elicio Therapeutics, Inc.

CEL-SCI Corp.

Intensity Therapeutics, Inc.

HCW Biologics Inc.

Syros Pharmaceuticals, Inc.

Why is Aspira Women's Health, Inc. ?

With a Negative Book Value, the company has a Weak Long Term Fundamental Strength

Poor long term growth as Operating profit has grown by an annual rate 6.07% of over the last 5 years
Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -23.15

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 207.72%, its profits have risen by 65.9%

Falling Participation by Institutional Investors

Institutional investors have decreased their stake by -6.4% over the previous quarter and collectively hold 5.74% of the company
These investors have better capability and resources to analyse fundamentals of companies than most retail investors

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Aspira Women's Health, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Aspira Women's Health, Inc.

249.21%

-0.41

209.91%

S&P 500

13.68%

0.71

19.28%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

15.67%

EBIT Growth (5y)

6.07%

EBIT to Interest (avg)

-23.15

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

1.41

Sales to Capital Employed (avg)

0.06

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

5.74%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

-3.50

EV to EBIT

-1.29

EV to EBITDA

-1.30

EV to Capital Employed

-1.95

EV to Sales

1.39

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

Negative BV

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bullish

No Trend

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

20What is working for the Company

OPERATING CASH FLOW(Y)

Highest at USD -6.06 MM

OPERATING PROFIT(Q)

Highest at USD -1.53 MM

OPERATING PROFIT MARGIN(Q)

Highest at -66.33 %

RAW MATERIAL COST(Y)

Fallen by 0.07% (YoY

DEBTORS TURNOVER RATIO(HY)

Highest at 7.26 times

PRE-TAX PROFIT(Q)

Highest at USD -0.58 MM

NET PROFIT(Q)

Highest at USD -0.58 MM

-7What is not working for the Company

INTEREST(HY)

At USD 0.03 MM has Grown at 73.33%

INVENTORY TURNOVER RATIO(HY)

Lowest at 11.79 times

Here's what is working for Aspira Women's Health, Inc.

Operating Cash Flow

Highest at USD -6.06 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Operating Profit

Highest at USD -1.53 MM and Grown

In each period in the last five periods

MOJO Watch

Near term Operating Profit trend is quite positive

Operating Profit (USD MM)

Operating Profit Margin

Highest at -66.33 % and Grown

In each period in the last five periods

MOJO Watch

Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit

Highest at USD -0.58 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Pre-Tax Profit

At USD -0.58 MM has Grown at 73.88%

over average net sales of the previous four periods of USD -2.23 MM

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Net Profit

Highest at USD -0.58 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (USD MM)

Net Profit

At USD -0.58 MM has Grown at 73.88%

over average net sales of the previous four periods of USD -2.23 MM

MOJO Watch

Near term Net Profit trend is positive

Net Profit (USD MM)

Debtors Turnover Ratio

Highest at 7.26 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by 0.07% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Aspira Women's Health, Inc.

Interest

At USD 0.03 MM has Grown at 73.33%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Inventory Turnover Ratio

Lowest at 11.79 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio